Pear Therapeutics, Inc. filed an asset purchase agreement in the US Bankruptcy Court for the sale of certain assets on May 20, 2023. As per the agreement dated May 20, 2023, seeks the Court?s approval for the sale of certain assets to Nox Health Group, Inc. for a purchase price of $3.90 million in cash plus assumption of the assumed liabilities plus any cure costs. The debtor?s assets include assets related to Somryst.

The buyer is represented by Robert Lystad of Bryan Cave Leighton Paisner LLP as its legal advisor.